Identifying genetic drivers of innate immunity using custom targeted CRISPR screens

27 Apr 2022

This application note dives into recent research from Boehringer Ingelheim that utilized Twist Bioscience’s silicon-based DNA synthesis platform to produce high-quality, customized oligos for CRISPR screens.

Links

Tags